GGG

TentativeAI MemoPost-earnings T+1

Graco

As of 2026-10-22/Post-earnings T+1/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-22 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q4 revenue guidance and order conversion • 2027-01-27

Base target: $82 / p=45% prob

Biggest risk

Adjusted operating earnings grew just 1% against 8% sales growth, and Valco Melton was loss-making in its first reported post-close period. The reported EPS and revenue misses complicate the prior constructive thesis. [#10-Q-2026-10-21]

Invalidation

Break below $68 or thesis failure.

What would change my mind?

Organic orders and sales grew despite mixed end markets. Sustained conversion, stronger acquired-business margins and ABB commercialization could support upside. [#PR-2026-10-21]

Research note

Recommendation

—

Confidence

medium

As of

2026-10-22

Base target

$82

p=45%

Bull target

$94

p=25%

Bear target

$68

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Post-earnings margin and valuation reassessment
Valco Melton integration and ABB technology commercialization
Organic orders and sales grew despite mixed end markets.

BearKey bullets

Higher product costs could continue to absorb price realization and restrain margins.
[#10-Q-2026-10-21]
Management described end-market conditions as mixed, making order conversion and Q4 revenue guidance execution uncertain.

WatchKey bullets

Q4 revenue guidance and order conversion

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+1

Base case: $82 (p=45%)

Target spread vs base: +15% / -17%

Scenario probabilities

Bull Target: $94 (p=25%)Base Target: $82 (p=45%)Bear Target: $68 (p=30%)

Commentary

The scheduled T+1 follow-up changes the prior constructive view to neutral monitoring, consistent with the deterministic neutral prior. Investing.com reported adjusted EPS of $0.81 versus $0.83 consensus, revenue of $586.4 million versus $589.74 million consensus, and a 7.3% after-hours decline. That reaction is not yet a verified regular-session move. No post-print analyst revisions, options, short-interest or sufficient social data were available; zero sentiment-field values denote unavailable data, not neutral measurements. https://ng.investing.com/news/earnings/graco-falls-7-as-third-quarter-results-miss-estimates-2749645

As of 2026-10-22 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Organic orders and sales grew despite mixed end markets. Sustained conversion, stronger acquired-business margins and ABB commercialization could support upside. [#PR-2026-10-21]

Bear Case

Drivers

Scannable catalysts and supporting factors

Post-earnings margin and valuation reassessment
Valco Melton integration and ABB technology commercialization

Scenarios

Bull Target (Scenario probability)

$94 / p=25% prob

Base Target (Scenario probability)

$82 / p=45% prob

Bear Target (Scenario probability)

$68 / p=30% prob

Analysis 2026-10-22 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

-0.20

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2027-01-27
Q4 revenue guidance and order conversion
Graco guided Q4 revenue to $610–640 million after Q3 sales of $586.4 million. Q3 organic sales rose 4%, while incoming organic orders rose 7%; conversion into Q4 sales is the key near-term test. [#PR-2026-10-21] https://www.marketscreener.com/news/graco-reports-record-third-quarter-sales-ce785cd9dd8ef120
Prob 55.00% • Move 5.00% • Priced-in 50.00%

Short-term Catalysts

Next few weeks

Post-earnings margin and valuation reassessment
2026-10-30
Q3 adjusted operating earnings rose only 1% despite 8% sales growth, as price realization offset higher product costs. Adjusted EPS of $0.81 missed the $0.83 consensus reported by Investing.com, and shares fell 7.3% after hours; whether that reaction persists is unverified. [#10-Q-2026-10-21] [#SEC-10Q-2026-10-21] https://www.sec.gov/Archives/edgar/data/42888/000004288826000145/ggg-20260925.htm
Prob 60% • Move -4% • Priced-in 65%

Long-term Catalysts

Months to a year

Valco Melton integration and ABB technology commercialization
2027-10-22
The completed Valco Melton acquisition contributed $12 million of Q3 sales but a $5 million operating loss for the post-close period. Graco also announced an ABB license agreement for motor technology in data-center cooling. Integration economics and commercialization remain to be demonstrated. [#10-Q-2026-10-21] [#PR-2026-10-21] https://www.sec.gov/Archives/edgar/data/42888/000004288826000145/ggg-20260925.htm
Prob 45% • Move 7% • Priced-in 30%

Risks

Higher product costs could continue to absorb price realization and restrain margins. [#10-Q-2026-10-21]
Management described end-market conditions as mixed, making order conversion and Q4 revenue guidance execution uncertain. [#PR-2026-10-21]
The ABB agreement does not establish near-term data-center revenue or deployment economics.
Valco Melton integration and acquisition-related costs could delay earnings contribution; its initial post-close operating result was a loss. [#10-Q-2026-10-21]

Peers

Symbol	Summary
MLI	Similarly sized capital-goods candidate; product mix differs, so it is a loose comparator.
EMR	Broad industrial-equipment comparator, but substantially larger and not a close product or valuation match.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-22

Loading AI feed…

Symbol

Summary

MLI

Similarly sized capital-goods candidate; product mix differs, so it is a loose comparator.

EMR

Broad industrial-equipment comparator, but substantially larger and not a close product or valuation match.